|
 |
MetaxaloneThis page contains recent news articles, when available, and an overview of Metaxalone but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Metaxalone (when available) Metaxalone is a skeletal muscle relaxant indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomforts associated with acute, painful musculoskeletal conditions. The mode of action of this drug has not been clearly identified, but may be related to its sedative properties. Metaxalone does not directly relax tense skeletal muscles in man. For the treatment of painful musculoskeletal conditions Mechanism Of Action: The mechanism of action of metaxalone in humans has not been established, but may be due to general central nervous system depression. News Articles on Metaxalone King Pharmaceuticals: A Look Ahead to Dec 2009 Quarterly Results - Dec 31, 2009 In January 2009, a US District Court acted to invalidate two of King's US patents relating to Skelaxin® (metaxalone), a muscle relaxant. ... Seeking Alpha (blog) Generic Name: Metaxalone, pain, muscle relaxer, muscle relaxant - Nov 11, 2009 Skelaxin (generic name: Metaxalone) is a muscle relaxant with a low chance of drowsiness or side effects. It can provide relief of acute, painful muscle ... Pattaya Daily News King Pharmaceuticals Reports Strong Third Quarter 2009 Financial Results - Nov 5, 2009 Net sales of SKELAXIN ® (metaxalone) totaled $102 million during the third quarter of 2009, compared to $110 million during the same period of the prior ... WELT ONLINE The Hindu Business Line - Jan 29, 2005 Dabur Pharma has received the USFDA approval for its bulk drug plant in Kalyani, West Bengal, for metaxalone, a muscle relaxant. ... Hindu Business Line King Pharma's Golden Deal - Jan 8, 2008 Metaxalone, or Skelaxin as called by King Pharmaceuticals, is a muscle relaxant used to relieve pain caused by strains or sprains. ... Forbes Loislaw Federal District Court Opinions - KING PHARMACEUTICALS, … - Dec 1, 2008 King does not dispute that the FDA investigation is unrelated to Eon's metaxalone ANDA or its metaxalone product. Instead, King posits that if, ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw King Pharmaceuticals Announces Cross-License Agreement With Mutual … - Dec 9, 2005 Pursuant to the agreement, King will pay Mutual an upfront payment of $35 million and royalties on net sales of products containing metaxalone. ... RedOrbit King Pharmaceuticals Reports FDA Approval of New Skelaxin(R) Label. - Dec 4, 2006 Metaxalone does not directly relax tense skeletal muscles in man. The most frequent reactions to metaxalone include nausea, vomiting, gastrointestinal upset ... Free with registration - Business Wire - AccessMyLibrary.com Loislaw Federal District Court Opinions - KING PHARMACEUTICALS, … - Jul 15, 2008 In Page 2 particular, more than a year ago, in related litigation involving 400 mg metaxalone tablets, Eon argued to Judge Trager that "the facts and ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Skeletal Muscle Relaxants (Systemic). - Feb 1, 2006 Studies in animals with metaxalone have not shown that it causes birth defects. ... It is not known whether chlorphenesin, chlorzoxazone, metaxalone, ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Use of Muscle Relaxants for Musculoskeletal Conditions Reviewed - Aug 5, 2008 Although methocarbamol and metaxalone are less sedating than tizanidine and ... Metaxalone is prescribed at 800 mg 3 to 4 times daily and is not recommended ... Medscape 'Prisoner' of Part D, Since the Medicare plan began on Jan. 1,... - Mar 17, 2006 Marek had been on the muscle relaxant metaxalone for years, Argoff said. But her new drug plan wouldn't pay for that drug. Argoff's staff spent six or seven ... Pay-Per-View - Newsday - ProQuest Archiver King and Mutual to share metaxolone IP.(King Pharmaceuticals Inc. and... - Dec 19, 2005 As part of the deal, King will pay Mutual an upfront fee of $35.0 million and royalties on net sales of products containing metaxalone. ... Free with registration - Pharma Marketletter - AccessMyLibrary.com 国王制è?¯ä¸ŽMutual Pharmaç¾è®¢è®¸å?¯å??è®® - Dec 10, 2005 Inc.å°±æŸ?些与metaxalone有关的智慧财产æ?ƒè¾¾æˆ?了许å?¯å??议。 æ ¹æ?®å??议，国王制è?¯å°†é¦–次 支付3500万美元给Mutual，以å?Šä»Žå?«æœ‰metaxalone的产å“?净销售收入收å?–æ?ƒåˆ©é‡‘。 ... 新浪网 Treatment of acute low back pain: use of medications: reduction and … - Feb 1, 2005 Metaxalone has been noted to cause little or no sedation, but its efficacy is not well supported. Opioid analgesics These agents are an option for patients ... $4.95 - Journal of Musculoskeletal Medicine - ECNext Article: Cephalon's revenue soars with Provigil. - Philadelphia... - Aug 4, 2006 1987, said he believes Cephalon can get "significant penetration ... helping drive sales growth at Cephalon. Baldino pointed to Skelaxin (metaxalone ... ... Pay-Per-View - Philadelphia Inquirer - HighBeam Research King Pharmaceuticals Reports Second-Quarter 2007 Financial Results.( … - Aug 7, 2007 Net sales of SKELAXIN([R]) (metaxalone) totaled $108 million during the second quarter of 2007, an increase of 11% compared to $97 million during the same ... Free with registration - Business Wire - AccessMyLibrary.com King Pharmaceuticals Reports First-Quarter 2007 Financial Results - May 10, 2007 Net sales of SKELAXIN(R) (metaxalone) totaled $112 million during the first quarter of 2007, an increase of 14% compared to $99 million during the same ... Genetic Engineering News - Genetic Engineering News (press release) King Pharmaceuticals Reports Second-Quarter 2006 Financial Results. - Aug 9, 2006 Net sales of Skelaxin(R) (metaxalone) totaled $97 million during the second quarter of 2006, an increase of 12% compared to $87 million during the same ... Free with registration - Business Wire - AccessMyLibrary.com King Pharmaceuticals Completes Strategic Acquisition of AVINZA(R) - Feb 26, 2007 SKELAXIN(R) (metaxalone): For patients with acute, painful musculoskeletal conditions as an adjunct to rest, physical therapy and other measures. ... Genetic Engineering News - Genetic Engineering News (press release) PRESS RELEASE: King Pharmaceuticals to Cut Costs, 20 Percent of … - Oct 19, 2007 In recent years, King has developed a strong pain management franchise, which includes existing products like SKELAXIN® (metaxalone) and AVINZA® (morphine ... FierceBiotech King Pharmaceuticals Reports Second-Quarter 2008 Financial Results - Aug 7, 2008 Net sales of SKELAXIN(R) (metaxalone) totaled $107 million during the second quarter of 2008, compared to $108 million during the same period of the prior ... Genetic Engineering News - Genetic Engineering News (press release) King Pharmaceuticals Joins Together Rx Access(TM) To Help Americans … - Jun 11, 2007 Skelaxin(R) (metaxalone); Avinza(R)(morphine sulfate extended release); Sonata(R) (zaleplon); and Levoxyl(R) (levothyroxine sodium tablets, USP). ... Genetic Engineering News - Genetic Engineering News (press release) King Pharmaceuticals Reports First-Quarter 2005 Financial Results - Sep 5, 2005 ...particularly with respect to Altace(R) (ramipril) and Skelaxin(R) (metaxalone), and significantly higher net sales of Thrombin-JMI(R) (thrombin, ... Euro am Sonntag King Pharmaceuticals Reports First-Quarter 2006 Financial Results - Sep 5, 2006 Net sales of Skelaxin(R) (metaxalone) totaled $99 million during the first quarter of 2006, an increase of 37% compared to $72 million during the same ... Euro am Sonntag How effective are muscle relaxers? - Aug 10, 2008 Cyclobenzaprine hcl has the most recent and largest clinical trials demonstrating its benefit, but , diazepam and metaxalone also appear to be effective. ... MedIndia What Are Headaches? What Causes Headaches? - Jun 13, 2007 Some patients find that metaxalone (Skelaxin), a non-sedating muscle relaxant helps. In the most severe cases patients have improved when given a ... Medical News Today - Medical News Today (press release) King Pharmaceuticals Reports Third-Quarter 2005 Financial Results - Sep 11, 2005 Net sales of Skelaxin(R) (metaxalone) increased 92% to $115.9 million during the third quarter of 2005 from $60.4 million during the same period of the ... Euro am Sonntag King Pharmaceuticals Reports Third-Quarter 2007 Financial Results.( … - Nov 8, 2007 Net sales of SKELAXIN([R]) (metaxalone) totaled $106 million during each of the third quarters of 2007 and 2006. THROMBIN-JMI([R]) (thrombin, topical, ... Free with registration - Business Wire - AccessMyLibrary.com King Pharma ends Skelaxin patent suit; CorePharma will get generic … - Jan 11, 2008 ...based King said it signed a metaxalone 800 mg product agreement on Jan. 2 granting CorePharma certain rights for an authorized generic version of the ... Kingsport Times News King Pharmaceuticals Announces Strategic Acquisition of Avinza(R)... - Sep 7, 2006 ...--SKELAXIN(R) (metaxalone): A non-narcotic and non-addictive muscle relaxant that brings relief to muscle regions affected by pain and discomfort, ... Free with registration - Business Wire - AccessMyLibrary.com King's 2nd-qtr sales rise 8%, Rx income up 5%.(financial report)(Finan... - Aug 21, 2006 ...jumped 7% $154.0 million, while the muscle relaxant Skelaxin (metaxalone) increased 12% to $97.0 million. Sales of the coagulant Thrombin-JMI (thrombin, ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Lose that pain in the neck: simple treatments can alleviate most neck... - Oct 1, 2007 While muscle relaxants--carisoprodol, metaxalone and others--may alleviate acute neck pain, they're not so effective for chronic pain, Dr. Mazanec said. ... Free with registration - Men's Health Advisor - AccessMyLibrary.com CorePharma to Sell Authorized Generic Skelaxin - Jan 16, 2008 Under the agreement relating to 800-mg Skelaxin (metaxalone) tablets, CorePharma's license will go into effect Dec. 1, 2012, or six months after the US ... FDA news - FDA news (subscription) King Pharmaceuticals and Pain Therapeutics Enter Into Strategic... - Nov 10, 2005 King's growing line of branded products includes neuroscience drugs such as Skelaxin(R) (metaxalone) and Sonata(R) (zaleplon). ... $4.95 - PR Newswire - ECNext King sees 1st-qtr earnings drop 28% to $51M.(Brief article) - May 29, 2006 ...sales of which contributed $159.0 million, up 85% on the first quarter of last year; revenues from its muscle relaxant Skelaxin (metaxalone) rose 37% to ... Free with registration - Pharma Marketletter - AccessMyLibrary.com BENZODIAZEPINE (Oral route, Parenteral route, Rectal route).(Drug … - May 1, 2007 Metaxalone * Methocarbamol * Methohexital * Mibefradil * Morphine * Morphine Sulfate Liposome * Omeprazole * Oxycodone * Oxymorphone * Pentobarbital ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Cape Cod Times : Falmouth District Court - Feb 21, 2008 ANDRADE, Douglas H. Jr., 20, 65 O'Donnell Ave., East Falmouth; possessing marijuana, possessing metaxalone, Friday in Falmouth. Pretrial hearing March 25. ... $2.95 - Cape Cod Times - NewsBank Kava. - May 1, 2006 Medicines used for muscle spasms (examples: Carisoprodol (Soma(R)); Methocarbamol (Robaxin(R)); Metaxalone (Skelaxin(R))) * Tacrine (Cognex(R)) ... Free with registration - AltCareDex Alternative Medicines - AccessMyLibrary.com Cape Cod Times : Falmouth District Court - Jun 30, 2008 15 in Falmouth, continued six months without a guilty finding; possessing metaxalone, dismissed. ANDREWS, Michael P., 20, 242 East Falmouth Highway, ... $2.95 - Cape Cod Times - NewsBank King Pharmaceuticals Reports First-Quarter 2005 Financial Results. - May 9, 2005 ...particularly with respect to Altace(R) (ramipril) and Skelaxin(R) (metaxalone), and significantly higher net sales of Thrombin-JMI(R) (thrombin, ... $4.95 - PR Newswire - ECNext King Pharmaceuticals Accelerates Strategic Shift to Maximize Long... - Oct 18, 2007 In recent years, King has developed a strong pain management franchise, which includes existing products like SKELAXIN([R]) (metaxalone) and AVINZA([R]) ... $4.95 - Business Wire - ECNext King Pharmaceuticals Reports Third-Quarter 2005 Financial Results. - Nov 9, 2005 Net sales of Skelaxin(R) (metaxalone) increased 92% to $115.9 million during the third quarter of 2005 from $60.4 million during the same period of the ... $4.95 - PR Newswire - ECNext King Pharmaceuticals Reports First-Quarter 2006 Financial Results. - May 9, 2006 Net sales of Skelaxin(R) (metaxalone) totaled $99 million during the first quarter of 2006, an increase of 37% compared to $72 million during the same ... $4.95 - PR Newswire - ECNext Loislaw Federal District Court Opinions - KING PHARMACEUTICALS, … - Dec 4, 2008 ...the "factual bas[e]s" for "King's contention[s]" or (in the case of Topic 34) "King's understanding of how Eon will sell its 800 mg metaxalone product . ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw US workers' comp Rx costs rate of rise slows, but expensive new drugs... - May 2, 2005 ...such as Pfizer's Zoloft (sertraline), sleep aids including Sanofi-Aventis' Ambien (zolpidem) and muscle relaxants, eg, King Pharma's Skelaxin (metaxalone). $4.95 - Pharma Marketletter - ECNext Federal Register 2007 - 72 FR 30386 Draft Guidances for Industry … - May 31, 2007 Sodium Losartan Potassium M Mefloquine HCl Meloxicam (multiple dosage forms) Mercaptopurine Mesalamine Metaxalone Metformin HCl Metformin HCl; ... Pay-Per-View - Federal Register 2007 - Loislaw King's profit drops 34% in 2nd-qtr 2008 to $43M. - Aug 18, 2008 Sales of muscle relaxant Skelaxin (metaxalone) were largely flat at $107.0 million versus $108.0 million in second-quarter 2007, while hemostatic agent ... $9.94 - Pharma Marketletter - Alacra Store King's 3rd-qtr revenue drops 5% to $492M. - Nov 27, 2006 Sales of Altace (ramipril), King's cardiovascular drug, totaled $159.0 million vs $174.0 million, while the muscle relaxant Skelaxin (metaxalone) fell to ... $9.94 - Pharma Marketletter - Alacra Store King's 2nd-qtr revenue rises 9%, net income falls. - Aug 20, 2007 Sales of Altace (ramipril), King's cardiovascular drug, rose to $163.0 million from $154.0 million, while the muscle relaxant Skelaxin (metaxalone) earned ... $9.94 - Pharma Marketletter - Alacra Store King Pharma third qtr revenues up 31%.(King Pharmaceuticals Inc.)(Brie... - Nov 21, 2005 ..." In addition, the firm notes that sales of its products Skelaxin (metaxalone), Thrombin JM (thrombin, topical, bovine USP) and Levoxyl (levothyroxine ... $4.95 - Pharma Marketletter - ECNext Press Release: King Pharmaceuticals Reports First-Quarter 2005 … - May 9, 2005 ...particularly with respect to Altace(R) (ramipril) and Skelaxin(R) (metaxalone), and significantly higher net sales of Thrombin-JMI(R) (thrombin, ... Pay-Per-View - PR Newswire - HighBeam Research Options for osteoarthritis pain: despite concerns about certain pain ... - Jul 1, 2006 Muscle relaxants (carisoprodol, chlorzoxazone, cyclobenzaprine, methocarbamol, metaxalone, oxybutynin) * Nifedipine, short-acting * Nitrofurantoin * NSAIDs, ... Pay-Per-View - Men's Health Advisor - HighBeam Research Janssen's Invega.(PRODUCT NEWS) | Article from Medical Marketing & … - Feb 1, 2007 Elan has announced FDA approval for a new 800 mg strength version of Skelaxin (metaxalone) for the treatment of acute pain in musculoskeletal conditions. ... Pay-Per-View - Medical Marketing & Media - HighBeam Research King Pharmaceuticals Appoints Joseph Squicciarino Chief Financial … - Jun 1, 2005 Altace(R) (ramipril), Skelaxin(R) (metaxalone), Levoxyl(R) (levothyroxine sodium tablets, USP), Sonata(R) (zaleplon) and Thrombin-JMI(R) (thrombin, ... $4.95 - PR Newswire - ECNext King's 1st-qtr 2007 revenue increases 7%. - May 21, 2007 Top performers included the muscle relaxant Skelaxin (metaxalone) which earned $112.0 million, an increase of 14%, while sales of the firm's ... $9.94 - Pharma Marketletter - Alacra Store GlaxoSmithKline.(Pipeline) | Article from Medical Marketing & Media |... - Aug 1, 2006 Elan has announced FDA approval for a new 800 mg strength version of Skelaxin (metaxalone) for the treatment of acute pain in musculoskeletal conditions. ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Loislaw Federal District Court Opinions - WRENN v. BARNHART (NH … - Jun 27, 2005 Dr. Thies thus concluded that Wrenn's discomfort may have resulted from musculoskeletal etiology[fn6] and prescribed Metaxalone.[fn7] Four weeks later, ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw TALK TO THE DOC Back pain can be wake-up call - Jun 20, 2007 Prescription muscle relaxants such as cyclobenzaprine (Flexeril) and metaxalone (Skelaxin) also appear to be effective. ... $2.95 - Ojai Valley News - NewsBank Shire's Lialda.(PRODUCT NEWS) | Article from Medical Marketing & … - Mar 1, 2007 Elan has announced FDA approval for a new 800 mg strength version of Skelaxin (metaxalone) for the treatment of acute pain in musculoskeletal conditions. ... Pay-Per-View - Medical Marketing & Media - HighBeam Research PHARMtechexpo 2005 Exhibitor Profiles. - Feb 7, 2005 METAXALONE 11.MICONAZOLE BASE 12.MICONAZOLE NITRATE 13.OXYBUTYNIN HYDROCHLORIDE 14.SALBUTAMOL BASE 15.SALBUTAMOL SULPHATE 16.TIMOLOL MALEATE 17. ... $4.95 - Business Wire - ECNext King Pharmaceuticals Reports Second-Quarter 2005 Financial Results. - Aug 9, 2005 Net sales of Skelaxin(R) (metaxalone) increased 71% to $86.8 million during the second quarter of 2005 from $50.9 million during the same period of the ... $4.95 - PR Newswire - ECNext Press Release: King Pharmaceuticals Reports Third-Quarter 2005 … - Nov 9, 2005 Net sales of Skelaxin(R) (metaxalone) increased 92% to $115.9 million during the third quarter of 2005 from $60.4 million during the same period of the ... Pay-Per-View - PR Newswire - HighBeam Research King Pharmaceuticals Announces Appointment of Eric J. Bruce as … - Jun 10, 2005 Altace(R) (ramipril), Skelaxin(R) (metaxalone), Levoxyl(R) (levothyroxine sodium tablets, USP), Sonata(R) (zaleplon) and Thrombin-JMI(R) (thrombin, ... $4.95 - PR Newswire - ECNext King Pharma 1st-qtr income rises 26%.(Brief Article) - May 23, 2005 ...particularly for Altace (ramipril) and Skelaxin (metaxalone), and significantly higher net sales of Thrombin-JMI (thrombin, topical, bovine). $4.95 - Pharma Marketletter - ECNext Georgia Code - 16-13-71. (a) A "dangerous drug" means any drug other ... - Aug 4, 2005 ...(572) Metaxalone; (572.5) Metformin; (573) Methacholine; (574) Methacycline; (575) Methallenestril; (576) Reserved; (577) Reserved; (578) Methantheline; ... Pay-Per-View - Georgia Code - Loislaw Article: Second quarter drives Novartis towards record. - The Evening... - Jul 14, 2005 Article: FDA Responds to Eon Labs' Metaxalone Biostudy. Business Wire; March 24, 2003 ; 665 words ... ... BUSINESS WIRE)--March 24, 2003 Eon Labs, ... Pay-Per-View - Evening Standard - HighBeam Research Article: Novartis snaps up German rival. - The Evening Standard... - Feb 21, 2005 Article: FDA Responds to Eon Labs' Metaxalone Biostudy. Business Wire; March 24, 2003 ; 665 words ... ... BUSINESS WIRE)--March 24, 2003 Eon Labs, ... Pay-Per-View - Evening Standard - HighBeam Research Article: Novartis creates a drugs giant with [pounds sterling]3.9bn... - Feb 21, 2005 Article: FDA Responds to Eon Labs' Metaxalone Biostudy. Business Wire; March 24, 2003 ; 665 words ... ... BUSINESS WIRE)--March 24, 2003 Eon Labs, ... Pay-Per-View - Evening Standard - HighBeam Research Brand Names/Synonyms: Metaxalone is also known by the following brand names and/or synonyms.Meta.Xalon; .Meta.Xalone; .Meta.Zalone; .Meta.Zolone; AHR 438; AHR-438; HSDB 3236; Metassalone [Dcit]; Metaxalon; Metaxalona [Inn-Spanish]; Metaxalona [Spanish]; Metaxalone; Metaxalone [Usan:Ban:Inn]; Metaxalonum [Inn-Latin]; Metaxalonum [Latin]; Metazalone; Metazolone; Methaxalonum; Methoxolone; Skelaxin; Zorane Drug Category: Metaxalone is categorized under the following by the FDA: Muscle Relaxants, skeletal muscle; Analgesics; Hypnotics and Sedatives; Dosage Forms: Tablet Absorption: Not Available Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 5-[(3,5-dimethylphenoxy)methyl]oxazolidin-2-one |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
